Health Canada has not approved BPC-157 as a health product or prescription drug
BPC-157 is a signaling peptide that upregulates growth factors involved in tissue repair, particularly VEGF (new blood vessel formation), fibroblast activity (collagen production), and nitric oxide signaling
BPC-157 is also classified by WADA as a prohibited substance for competitive athletes, which is a regulatory consideration separate from safety
Opioids block pain signals
Athletes managing a hamstring strain, a grade II calf tear, or chronic muscle tension patterns that are limiting training load are a common profile in our Miami practice
Based on what we see at our Doral clinic, the patients who benefit most look like this: A soft-tissue injury that stalled: physical therapy is complete, there is no surgical indication, but the patient is still symptomatic at 8 to 12 weeks